Investor Alert

Cerecor Inc.



After Hours

 --Quotes are delayed by 20 min

Jul 23, 2021, 7:59 p.m.





+0.11 +3.86%


Volume 16,298

Quotes are delayed by 20 min


Previous close

$ 2.90

$ 2.85


-0.05 -1.72%

Day low

Day high




52 week low

52 week high




Joseph M. Miller

Joseph M. Miller occupies the position of Chief Financial Officer of Aurinia Pharmaceuticals, Inc. Mr. Miller is also on the board of Cerecor, Inc.

Mr. Miller previously was Chief Financial Officer & Vice President-Finance of Eppendorf-5 Prime, Inc., Senior Director-Accounting at Qiagen Genomics, Inc. and Vice President-Finance of Sucampo Pharmaceuticals, Inc.

Joseph M. Miller received an undergraduate degree from Villanova University.


Date Shares Transaction Value
06/08/2020 4,472   Derivative/Non-derivative trans. at $3.22 per share. 14,400
12/10/2019 2,598   Acquisition at $2.85 per share. 7,404
06/07/2019 3,723   Derivative/Non-derivative trans. at $4.85 per share. 18,057
07/12/2018 45,000   Award at $0 per share. 0

Officers and Executives

Mr. Michael F. Cola
Chairman & Chief Executive Officer
Mr. Schond L. Greenway
Chief Financial Officer & Treasurer
Dr. Garry Arthur Neil
Chief Scientific Officer
Dr. H. Jeffrey Wilkins
Chief Medical Officer
Dr. Younok Dumortier Shin
Chief Technology Officer
Dr. Lisa Hegg
Vice President-Research & Development Programs
Mr. James A. Harrell
Chief Commercial Officer
Mr. Joseph M. Miller
Mr. Christopher Sullivan
Chief Accounting Officer
Ms. Colleen Matkowski
Vice President-Global Regulatory Affairs
Dr. Suzanne Louise Bruhn
Lead Independent Director
Dr. Gilla Kaplan
Independent Director
Dr. Gunnar Magnus Modee Persson
Independent Director
Mr. Phillip P. Gutry
Independent Director
Mr. Steven Joseph Boyd
Independent Director
Link to MarketWatch's Slice.